NCT00986102 PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region Status COMPLETED Phase PHASE4
NCT00965848 A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections Status COMPLETED Phase PHASE4
NCT00900653 Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women Status UNKNOWN Phase PHASE4
NCT00795470 Factorial Trial of Antimicrobial Therapy and/or Catheter Change for Catheter Urinary Tract Infections. Status WITHDRAWN Phase PHASE3
NCT00781625 Probiotics as a Prophylactic Aid in Women With Recurrent Urinary Tract Infections (UTI's) Status UNKNOWN Phase NA
NCT00771316 Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054) Status TERMINATED Phase PHASE3
NCT00731315 Computer-Assisted Treatment of Urinary Tract Infection in Emergency Departments and Community Health Centers Status TERMINATED Phase NA
NCT00722735 Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI) Status COMPLETED Phase PHASE2
NCT00672503 Decreasing Catheter-Associated Urinary Tract Infections in the Pediatric Intensive Care Unit Status COMPLETED Phase N/A
NCT00638170 Cranberry Juice in the Prevention of Urinary Tract Infections in Children Status COMPLETED Phase NA
NCT00598403 Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis Status COMPLETED Phase PHASE3
NCT00594594 Adjuntive Probiotic Therapy in Treating Urinary Tract Infections in Spinal Cord Injury Status TERMINATED Phase PHASE1
NCT00591240 A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection Status COMPLETED Phase N/A
NCT00583648 Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department? Status WITHDRAWN Phase NA
NCT00481689 Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens Status COMPLETED Phase PHASE4